-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/LPaUxRbrTshfsYVVTzenEQ
April 26, 2022 - It is important to note that increasing age heavily influ-
ences the ACC/AHA estimated 10-year CVD event … have initiated aspirin use, the net benefits continue to accrue over
time in the absence of a bleeding event
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/BXkaHRFGjwUCoyANeMSuTz
January 01, 2010 - numbers needed to treat (NNT)
over 5 years ranged from 200 to 400 to prevent
1 congestive heart failure event … ranged from
approximately 900 to prevent 1 stroke to 10,000
to prevent 1 case of coronary heart disease event … The number needed
to treat over 5 years to prevent 1 cardiovascular
event was 18 (95% CI 17 to 19) in
-
www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/tobacco-smoking-cessation-in-adults-including-pregnant-women-interventions
June 02, 2020 - in progress
Draft Recommendation Statement
Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Persons
June 02, 2020
Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality…
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/tobacco-use-in-adults-and-pregnant-women-counseling-and-interventions-september-2015
September 21, 2015 - compared with those receiving placebo (RR, 1.36 [CI, 1.03 to 1.81]), but the type of serious adverse event
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/mf27sR5jgcrqcaY9t8d8Jt
April 04, 2022 - RR, 2.40 [95% CI, 0.71-19.32]; I2 = 0%) (eFigure 8 in the
Supplement),21,37,41,90,106 or any adverse event … , 0.59-4.03]; I2 = 82%).41,76,77 However,
estimates were imprecise and the estimate for any adverse event … The LiGHT trial found no differences between SLT and medical
therapy in likelihood of any adverse event … placebo/no treatment in risk of serious adverse
events, withdrawal due to adverse events,
or any adverse event … to 2.07), withdrawal due to adverse events
(3 trials, n = 1875; RRs, 4.73 to 38.20),
and any adverse event
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/cardiovascular-disease-risk-screening-with-electrocardiography
July 14, 2016 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
Final Research Plan
Cardiovascular Disease Risk: Screening With Electrocardiography
July 14, 2016
Recommendations made by the USPSTF are independent of the U.S. government. …
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/qWZxPBqpffTYVNvGYPkohz
May 01, 2021 - Screening for Anxiety in Children and Adolescents: US Preventive Services Recommendation Statement
Screening for Anxiety in Children and Adolescents
US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force
Summary of Recommendations
See the Summary of Recommendations figure.
Imp…
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/screening-for-prediabetes-and-type-2-diabetes
August 24, 2021 - with moderate or high strength of evidence (for benefit), using the pooled RRs and the control group event … all-cause mortality, cardiovascular-related mortality, and the occurrence of a first cardiovascular event … with placebo (liraglutide, sitagliptin, metformin, nateglinide, and rosiglitazone plus metformin); event
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/peripheral-arterial-disease-pad-and-cvd-in-adults-risk-assessment-with-ankle-brachial-index-2013
September 15, 2013 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Final Recommendation Statement
Peripheral Arterial Disease (PAD) and CVD in Adults: Risk Assessment with Ankle Brachial Index
September 15, 2013
Recommendations ma…
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/vitamin-d-calcium-combined-supplementation-primary-prevention-falls-fractures-communitydwelling-adults
April 06, 2023 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
in progress
Final Research Plan
Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Falls and Fractures in Community-Dwelling Adults: Preventive Medicatio…
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary16/blood-pressure-in-children-and-adolescents-hypertension-screening-october-2013
February 15, 2013 - Adverse event data were often poorly reported, and most studies reported noncomparative data from open-label … Headache was the most common specific adverse event in most studies: rates ranged from 2% to 33% in children … In one study, a combination of bisoprolol and hydrochlorothiazide was associated with lower adverse event … in the incidence of specific adverse events, including headache (the most commonly reported adverse event … withdrawal study
12.2 (2.97)
422 screened; 302 randomized
Olmesartan medoxomil
Any adverse event
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/menopausal-hormone-therapy-preventive-medication
May 27, 2021 - for HT use such as history of breast cancer, coronary heart disease, a previous venous thromboembolic event
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/Aqm6uW6_HrTRVJ-EVCVaRV
March 01, 2013 - al
though specific rates were not always
reported.53,54,56–59,68–71
Two studies pooled adverse event … reported no
active treatment and placebo arms, and significant difference between active
adverse event … rates overall ere not well- treatments and placebo in adverse event
reported in most studies. rates … one study, a combination of
bisoprolol and hydrochlorothiazide was
associated with lower adverse event … the
incidence of specific adverse events,
including headache (the most commonly
reported adverse event
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary27/screening-depression-suicide-risk-children-adolescents
October 11, 2022 - Comparable intensity of therapy in study groups, coupled with low-event rates for some outcomes (such
-
www.uspreventiveservicestaskforce.org/uspstf/document/behavioral-counseling-and-pharmacotherapy-interventions-for-/tobacco-use-in-adults-and-pregnant-women-counseling-and-interventions
September 21, 2015 - . 40 , 49 Nicotine replacement therapy was associated with an increased risk for any cardiovascular event … varenicline were superior to placebo for
smoking cessation and that none seemed to have an
adverse event … AE = adverse event; CV = cardiovascular; ENDS = electronic nicotine delivery system; KQ = key question … AE = adverse event; KQ = key question; NA = not applicable; NRT = nicotine replacement therapy; SR = … 24, or 52 wk
No difference in frequency of AEs among study groups at each time point
AE = adverse event
-
www.uspreventiveservicestaskforce.org/uspstf/document/behavioral-counseling-and-pharmacotherapy-interventions-for-/tobacco-use-in-adults-and-pregnant-women-counseling-and-interventions-september-2015
September 21, 2015 - 40 , 49 Nicotine replacement therapy was associated with an increased risk for any cardiovascular event … varenicline were superior to placebo for
smoking cessation and that none seemed to have an
adverse event … AE = adverse event; CV = cardiovascular; ENDS = electronic nicotine delivery system; KQ = key question … AE = adverse event; KQ = key question; NA = not applicable; NRT = nicotine replacement therapy; SR = … 52 wk
No difference in frequency of AEs among study groups at each time point
AE = adverse event
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/4y3P9DxovKMEjNmVd2mrPp
December 01, 2007 - www.annals.org 18 December 2007 Annals of Internal Medicine Volume 147 • Number 12 873
vent 1 adverse health event … number of people who would need to be screened for
some defined period to prevent 1 adverse health event … number of people who would need to be treated or screened
for a defined time to cause 1 adverse health event
-
www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/breast-cancer-medications-for-risk-reduction
September 03, 2019 - Younger women with no risk factors for cardiovascular disease are less likely to have a cardiovascular event … Comparison of fracture, cardiovascular event, and breast cancer rates at 3 years in postmenopausal women … 5)
ND
ND
Harms: Events Increased (95% CI) a
Vascular
Venous thromboembolic event
-
www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/chronic-kidney-disease-screening
January 19, 2023 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
in progress
Draft Research Plan
Chronic Kidney Disease: Screening
January 19, 2023
Recommendations made by the USPSTF are independent of the U.S. government. They should not …
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/dvcAbDQWejyK38oxF8qgka
November 01, 2012 - ART (adjusted RR, 1.3
per year of exposure [CI, 1.1 to 1.4 per year of exposure]),
although absolute event … sex, HIV
transmission
group, race,
calendar year,
cohort, smoking,
family history of
CVD, previous CV
event … lamivudine,
abacavir
Age, sex, risk group,
race, cohort, BMI,
family history of
CVD, smoking,
previous CV
event … Age, sex,
cohort, HIV
transmission
group, race, age,
BMI, family
history of CVD,
smoking, previous
CV event